The blockage of the immune response with anti-inflammatory drugs reduced the progression of squamous cell carcinomas (SCCs). This strategy could be effective in treating up to 75 percent of human patients with SCC. The study reinforces the important role of inflammation in the development of cancers and opens up a new path for the treatment of the disease.

More...